The Cigna GroupMEX:CI 66 5-Year Yield-on-Cost % is 91.40 as of Jul. 09, 2026, which is 152% above its 10-year median of 36.22. GuruFocus rates MEX:CI with a GF Score™ of 66/100 and a GF Value™ of MXN7,448.55 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 9 Healthcare Plans companies, The Cigna Group ranks better than 88.89% on this metric.
The Cigna Group's yield on cost for the quarter that ended in Mar. 2026 was 91.40.
The historical rank and industry rank for The Cigna Group's 5-Year Yield-on-Cost % or its related term are showing as below:
MEX:CI'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.84 Med: 36.22 Max: 102.35
Current: 91.4
During the past 13 years, The Cigna Group's highest Yield on Cost was 102.35. The lowest was 0.84. And the median was 36.22.
MEX:CI's 5-Year Yield-on-Cost % is ranked better than 88.89% of 9
companies
in the Healthcare Plans industry
Industry Median: 2.95
vs MEX:CI: 91.40
The Cigna Group (MEX:CI) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
The Cigna Group 5-Year Yield-on-Cost % Related Terms
MEX:CI vs ELV, HUM, CNC: 5-Year Yield-on-Cost % Comparison
For the Healthcare Plans subindustry, The Cigna Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cigna Group 5-Year Yield-on-Cost % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, The Cigna Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where The Cigna Group's 5-Year Yield-on-Cost % falls into.
The Cigna Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of The Cigna Group is calculated as
The Cigna Group (MEX:CI) has a 5-Year Yield-on-Cost % of 91.40 as of Jul. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on The Cigna Group and its competitors. This is 152% above median its historical median of 36.22. Over the past decade, The Cigna Group's 5-Year Yield-on-Cost % has ranged from 0.84 to 102.35. According to the industry distribution chart, The Cigna Group ranks #1 out of 9 companies in the Healthcare Plans industry, placing it in the top 11.1%.
Is The Cigna Group's 5-Year Yield-on-Cost % too high?
The Cigna Group's current 5-Year Yield-on-Cost % of 91.40 is 152% above median its 10-year median of 36.22. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 102.35. The Healthcare Plans industry median 5-Year Yield-on-Cost % is 2.95. The Cigna Group's value of 91.40 is 2998.3% above this industry median. Based on the distribution chart, The Cigna Group ranks #1 out of 9 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, The Cigna Group has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's 5-Year Yield-on-Cost % compare to ELV and HUM?
According to the Healthcare Plans industry distribution chart, The Cigna Group ranks #1 out of 9 companies for 5-Year Yield-on-Cost %. This places The Cigna Group in the top 11% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.95. The Cigna Group's value of 91.40 is 2998.3% above this benchmark. Historically, The Cigna Group's own 5-Year Yield-on-Cost % has ranged from 0.84 to 102.35 over the past decade. While the company's 10-year median is 36.22 vs. the industry median of 2.95, The Cigna Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Plans company?
The median 5-Year Yield-on-Cost % among Healthcare Plans companies is 2.95, based on 9 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cigna Group's current 5-Year Yield-on-Cost % of 91.40 is 2998.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on The Cigna Group and its competitors. For the Healthcare Plans industry, the median 5-Year Yield-on-Cost % is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cigna Group's current 5-Year Yield-on-Cost % is 91.40, which is 152% above median its own 10-year median of 36.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (MEX:CI) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN7,448.55, compared to a current price of MXN5,050.00 — trading 32.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 91.40, which is 152% above median its 10-year median of 36.22 and 2998.3% above the Healthcare Plans industry median of 2.95. The Cigna Group's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For The Cigna Group (MEX:CI), the current 5-Year Yield-on-Cost % is 91.40 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cigna Group (MEX:CI) Overvalued in 2026?
Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued.
The current stock price of MXN5,050.00 is trading 32.2% below its estimated GF Value™ of MXN7,448.55.
GuruFocus considers The Cigna Group to be Significantly Undervalued.
Key valuation signals for MEX:CI:
5-Year Yield-on-Cost %: 91.40 (152% above median its 10-year median of 36.22)
GF Value™: MXN7,448.55 vs. price of MXN5,050.00 (32.2% below fair value)
Industry Position: 2998.3% above the Healthcare Plans median (#1 of 9)
No single metric tells the full story. See the MEX:CI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
66GF Score
Get the complete analysis for MEX:CI
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CI has been successfully added to your 